Thyssenkrupps, Naval

Thyssenkrupp's Naval Arm Delivers a Salvage While Hydrogen Unit Drags the Conglomerate Back Down

Published on 08/12/2026 at 15:02 | Redaktion boerse-global.de

Thyssenkrupp's defense unit lifts outlook on record orders, while hydrogen subsidiary Nucera slashes guidance after exiting SOEC production.

Thyssenkrupp Shares Rise as Defense Arm Soars, Nucera Cuts Guidance Again
Thyssenkrupp Illustration mit AI erstellt übermittelt durch boerse-global.de

The conglomerate's Wednesday trading session laid bare the widening gulf between its two most closely watched businesses. Marine Systems, the warship and submarine division, stormed ahead with a sharply raised outlook, while the separately listed hydrogen subsidiary Nucera was forced into yet another guidance cut — the second in as many months. Investors chose to reward the brighter story, pushing Thyssenkrupp shares up 3.74 percent to EUR 12.48 by midday.

A Record Order Book Gives TKMS Room to Aim Higher

The defense arm delivered a robust set of nine-month figures. Revenue climbed 19 percent to EUR 1.9 billion, while operating profit rose 13 percent to EUR 110 million — comfortably ahead of the EUR 101 million consensus. The order backlog swelled to a record EUR 20.1 billion by the end of June, providing rare visibility in a sector where order cycles run long.

That momentum prompted management to lift the full-year revenue forecast from a previously modest 2 to 5 percent growth range to a far more ambitious 10 to 12 percent. The operating margin is now expected to reach as high as 6.5 percent.

Demand is coming from multiple directions. Norway has ordered two submarines, Germany's navy has commissioned four frigates, and India is in talks over a further six boats. Canada, meanwhile, is viewed as a preferred bidder for a twelve-submarine program, though no contract has been finalized. TKMS chief Oliver Burkhard pointed to the division's strengthened competitive position, and Bernstein analyst Adrien Rabier suggested the consensus may soon need to revise its medium-term targets upward.

Nucera's SOEC Exit Triggers a Fresh Round of Cuts

The contrast with Nucera could hardly be starker. On the surface, order intake looked impressive — up 96 percent to EUR 471 million over the same nine-month period, helped by a major order from energy group Moeve for a 300-megawatt electrolyzer in Southern Europe. But the underlying numbers tell a different story.

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

Group revenue collapsed to EUR 354 million from EUR 663 million a year earlier, and EBIT swung to a loss of EUR 69 million against a profit of EUR 4 million in the prior-year period. The culprit is the company's decision to abandon plans for series production of SOEC stacks, a solid-oxide electrolysis technology. Management argued that in-house manufacturing simply did not offer an economically viable model. The retreat triggered a one-off charge of roughly EUR 30 million in the fourth quarter.

The revised guidance is notably weaker across the board. EBIT is now expected to land between minus EUR 105 million and minus EUR 75 million, versus the previous range of minus EUR 80 million to minus EUR 30 million. Revenue is pegged at EUR 450 million to EUR 500 million, and order intake at EUR 550 million to EUR 670 million — well below the earlier ceiling of EUR 850 million.

The split between divisions is telling. The chlor-alkali business held up reasonably well, with orders up 32 percent to EUR 288 million and EBIT of EUR 38 million. Green hydrogen, by contrast, suffered a sharp revenue decline and posted an EBIT loss of EUR 107 million. CFO Stefan Hahn emphasized the focus on cost control and financial flexibility, noting a net cash position of EUR 627 million as of June 30.

What the Divergence Means for the Parent

For the Thyssenkrupp mother stock, the defense impulse clearly carried the day. The shares now trade roughly 22 percent above their 200-day average and have gained more than a third since the start of the year. Still, the stock sits about six percent below its 52-week high of EUR 13.34, reached in October.

The backdrop is more complex than a single day's trading suggests. Shareholders recently approved the spin-off of materials trading unit tk accelis, which is slated for a stock market listing in the autumn, with the actual separation targeted for the end of October. Deutsche Bank Research reiterated its "Buy" rating on August 7, following the shareholder vote — a signal of confidence in the restructuring story, though the call is now several days old.

Market reaction to the spin-off news has been measured. The stock dipped 1.71 percent over the past seven days, a modest pullback that followed the announcement, but the longer-term trajectory remains firmly upward: a 33.49 percent gain year-to-date and 26.43 percent over twelve months. Technical indicators point to a healthy setup, with the RSI at 56.4 — neither overbought nor oversold.

The real test, however, lies ahead. Thursday's quarterly report from the parent company will show whether the operating businesses can match the strategic narrative. The spin-off was the straightforward part. Whether Thyssenkrupp can be dismantled into profitable standalone pieces is a question that will be answered by the numbers in the coming weeks — not by shareholder resolutions. For now, the naval division is carrying the weight, while the hydrogen ambitions that once promised growth have been pushed firmly to the back burner.

Ad

Thyssenkrupp Stock: New Analysis - 12 August

Fresh Thyssenkrupp information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Thyssenkrupp analysis...

Disclaimer...

en | DE0007500001 | THYSSENKRUPPS | boerse | 69940712 |